Diatron is a portfolio company of The Riverside Company, a global private equity firm focused on acquiring growing businesses valued at up to $200 million (€200 million in Europe). Founded in 1988, Riverside’s international portfolio now includes 80 companies, and it has more than $3 billion/€2.5 billion in assets under management. Diatron’s vision since the company’s foundation in 1989, is to become a worldwide leader in-vitro diagnostics, providing customers with a broad portfolio of high-quality tailored solutions. In its new production facility in Budapest, Hungary, the extensive R&D/Engineering team develops and manufactures compact hematology and clinical chemistry analyzers and reagents for the human medical and veterinary markets.
The Abacus 3CT is a compact, bench top, 60 test/hour, 3-part WBC differential analyzer with cap piercing for open and closed tube sampling with a new, easy to operate touch screen to access the new intuitive and logical user software. User friendly and easy to operate -The analyzer is simple to use via the high resolution touch screen user interface. Data entry is fast and efficient due to uploading from USB or via reading…
